Clinical trial
Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In…
NCT00348361 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00348361 |
|---|---|
| Title | Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever) |
| Official title | A Study to Validate Key Therapeutic Targets and Biomarkers During Allergen Exposure in Subjects With Allergic Rhinitis |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Allergic Rhinitis |
| Intervention type | Drug |
| Interventions | Fluticasone Propionate |
| Enrollment | 48 |
| Start date | Apr 1, 2005 |
| First posted | Jul 4, 2006 |
| Last update posted | Oct 13, 2008 |
| Countries | Netherlands, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: